Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Therapeutic Innovation & Regulatory Science|September 18, 2018
The Life Sciences Translational Challenge: The European PerspectiveRichard W Barker, Jack W ScannellPlos One|February 11, 2016
When Quality Beats Quantity: Decision Theory, Drug Discovery, and the Reproducibility CrisisJack W Scannell, Jim BosleyBMJ Open|June 8, 2017
Evidence for the effectiveness of minimum pricing of alcohol: a systematic review and assessment using the Bradford Hill criteria for causalitySadie Boniface, Jack W Scannell, Sally MarlowProceedings of the National Academy of Sciences of the United States of America|July 5, 2002
Estimating prokaryotic diversity and its limitsThomas P Curtis, William T Sloan, Jack W ScannellDrug Discovery Today|August 25, 2022
Biopharmaceutical R&D outsourcing: Short-term gain for long-term pain?Etienne Billette de Villemeur, Jack W Scannell, Bruno VersaevelNature Reviews. Drug Discovery|March 2, 2012
Diagnosing the decline in pharmaceutical R&D efficiencyJack W Scannell, Alex Blanckley, Helen Boldon, et al.JAMA Network Open|July 28, 2023
Costs and Causes of Oncology Drug Attrition With the Example of Insulin-Like Growth Factor-1 Receptor InhibitorsValerie Jentzsch, Leeza Osipenko, Jack W Scannell, et al.Reviews on Recent Clinical Trials|May 1, 2015
Realising the potential of adaptive development of medicinesRichard W Barker, Sarah GarnerNature Reviews. Drug Discovery|October 4, 2022
Predictive validity in drug discovery: what it is, why it matters and how to improve itJack W Scannell, James Bosley, John A Hickman, et al.Pharmacoeconomics|August 19, 2021
What Aspects of Illness Influence Public Preferences for Healthcare Priority Setting? A Discrete Choice Experiment in the UKLiz Morrell, James Buchanan, Sian Rees, et al.Pageof 2